Determining the accuracy of non-invasive biomarkers for detecting pre-cancerous colorectal neoplasia
- Conditions
- Bowel Cancer SurveillanceColorectal CancerInflammatory Bowel DiseasePre-cancerous colorectal neoplasiaCancer - Bowel - Back passage (rectum) or large bowel (colon)Public Health - Health service researchOral and Gastrointestinal - Inflammatory bowel disease
- Registration Number
- ACTRN12620000668909
- Lead Sponsor
- Flinders University of South Australia
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 3000
People booked for a colonoscopy at our approved study sites who are:
- Aged 18 years or over, and
- Experiencing gastrointestinal symptoms such as: abdominal pain, a change in bowel habit, weight loss, rectal bleeding (inclusive of microscopic rectal bleeding such as a positive faecal occult blood test), iron deficiency/anaemia, and/or gastrointestinal inflammation, OR living with inflammatory bowel disease, and
- Willing and able to provide a blood, stool, and/or tissue sample
None
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method